Executive Director & Acting CEO
Michael WilkinsonExecutive Director & Acting CEO
Michael Wilkinson is the Executive Chairman and Acting CEO of Minifab.
Michael has many decades of executive leadership experience including almost 20 years at the forefront of microfluidics device development and manufacture.
In 2002 Michael co-founded Minifab with Dr Erol Harvey and has remained the driving force behind its growth ever since. His primary focus is on leading Minfab’s business strategy and he is also highly engaged with the day-to-day operations of the business.
In addition to Minifab, Michael’s entrepreneurial experience includes founding and growing several successful businesses in the Pharmaceutical and Construction industries. He is also a founding board member of Small Technology Cluster, which promotes commercialization of next-generation biotechnologies, medical devices, life science and information technology.
Professor Erol Harvey
Non Executive Director
Professor Erol Harvey BSc (Hons), PhD, MIEE, CEng
Professor Erol Harvey (BSc (Hons), PhD, MIEE, CEng) has been involved in the commercial and scientific development of microtechnology for more that 15 years. His career spans industry as well as academia; the majority spent working in industry.
He was the Operations Manager for the SPRITE Ultra-high power Excimer laser at the Rutherford Appleton Laboratory in the UK before joining Exitech Limited, a spin-out company based in Oxford. He was responsible for the development of laser micromachining systems, and worked closely with clients in Japan, Far East, Europe and the USA to develop more than 80 novel products and processing techniques and has designed and implemented pilot scale facilities at more than 20 major sites globally.
In 1999 Erol returned to Australia to establish the microtechnology group at Swinburne University, where he is now Professor of MicroTechnology. Erol was instrumental in starting the CRC for microTechnology, and has recently partnered to form a spin-out company, Minifab (Aust) Pty Ltd in which he has performed the role of CEO since its creation.
Pat BolandNon-Executive Director
Pat Boland the founder and joint Managing Director of ANCA, a world leading Australian manufacturer of CNC tool grinders. Founded in 1974 in Melbourne, ANCA also has manufacturing sites in Thailand, Germany, the US, UK and Taiwan and 900 employees globally.
He has been awarded ‘engineering hero’ status by the Victorian Government and the 1999 Kernot Memorial Medal by Melbourne University. Amongst ANCA’s numerous awards are included Australian Exporter of the Year in 1995 and 2015, Large Advanced Manufacturer in the Australian Export awards in 2012 and Australian Endeavour awards Manufacturer of the Year for 2015.
he is active in the manufacturing industry and have several patents in the field of machine tools. I am the past President and a current Director of AMTIL, was a member of the Future Manufacturing Industry Innovation Council and has a first class Honours Degree in Electrical Engineering from Melbourne University.
Pat brings a life-time of experience in Australian based manufacturing for export markets. He also has experience in expanding a manufacturing base across multiple international locations.
Shaun HolthouseNon-Executive Director
When there was no commercial interest in their micro-technology research program, engineers Shaun Holthouse and Igor van de Griendt bought the intellectual property and built it into an application to improve the performance of athletes.
Founded in 2006, Catapult pioneered the use of wearable tracking technology in team sports and allowed, for the first time, sporting teams to track and analyse movement and make training and tactical decisions based on empirical data, rather than “gut feel” and “eye test”. Led by Shaun, Catapult launched on the ASX in 2014 and now has more than 300 staff in 16 countries, working with more than 1,800 elite teams from 35 different sports, including the AFL, NFL and NBA.
Most recently, Catapult launched a consumer business to expand its offering beyond elite sports to the mass market.
Mr Holthouse’s experience with sports technology is a close parallel to Minifab’s core business of helping customers develop ground breaking micro-engineered medical devices. Every device that Minifab develops represents a new break-through in medical technology that changes the way medicine is practiced around the world.
Aside from his experience in commercialising leading edge technology, Mr Holthouse brings with him an irrepressible entrepreneurial spirit as well as track record of successful capital raising. Both will be key to Minifab’s continued global expansion.